Dec 26 (Reuters) - Immunome Inc :
* IMMUNOME TO ACQUIRE ANTIBODY-RELATED ASSETS AND MATERIALS FROM ATRECA
* IMMUNOME INC - UNDER TERMS OF ASSET PURCHASE AGREEMENT, IMMUNOME WOULD PAY ATRECA A $5.5 MILLION UPFRONT PAYMENT
* IMMUNOME INC - UNDER TERMS OF ASSET PURCHASE AGREEMENT, IMMUNOME WOULD PAY ATRECA UP TO $7.0 MILLION IN CLINICAL DEVELOPMENT MILESTONES
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.